author-photo

Bruno Calabretta

Thomas Jefferson University
Temple University
University of Modena and Reggio Emilia

314

Papers

22434

Citations

Citation Trend

Filter By

Papers (314) Sort By

Journal Conference Others

Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (1)
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest differentiation in ARID1B-related neurodevelopmental disorders

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.

2021 Genes
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2538: Investigating the role of the oncogenic miR-17-92 cluster as involved in TKI-resistance enhancing the survival of MYB-dependent Ph+ acute lymphoblastic leukemia cells

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and independent effects by CDK6-specific PROTACs

2020 Blood
Show All
- Source
- Cite
- Save
Citations (20)
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions

2020
Show All
- Source
- Cite
- Save
Citations (14)
A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (11)
The 14q32.31 DLK1-DIO3 MIR300 tumor suppressor promotes leukemogenesis by inducing cancer stem cell quiescence and inhibiting NK cell anti-cancer immunity.

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
A phase I trial of palbociclib in combination with dexamethasone in relapsed or refractory adult B-cell acute lymphoblastic leukemia (ALL).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)